Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Cleveland Clinic, BioSig collaborate to gain insights into ablation

admin by admin
October 26, 2022
in News


BioSig Technologies this week announced it signed a master research agreement with the Cleveland Clinic to explore expanded indications for digital signal processing in arrhythmia care.

The Westport, Connecticut-based company will sponsor a research agreement with the Cleveland Clinic Foundation to investigate expanded clinical applications for the intracardiac signals that are acquired by its Pure EP system. Through the agreement, Cleveland Clinic will conduct physician-initiated scientific research investigating Pure EP potential to address common limitations of signal processing and signal use expansion during electrophysiology ablation procedures.

Cleveland Clinic was selected as the research partner based on its world-class physician faculty, research competency and mutual interest in using digital signal processing technology to advance the field of cardiac electrophysiology.

“As a non-profit, research, education, and healthcare institution, Cleveland Clinic has a long legacy of innovation in cardiovascular disease, and specifically in the field of electrophysiology. At BioSig, we embody their commitment to clinical discovery and ensuring that optimal treatments are made available to patients with efficiency and efficacy,” BioSig Chief Commercial Officer Gray Fleming said in a news release. “We are honored to align ourselves with Cleveland Clinic’s expertise as we discover new ways to positively impact procedural workflows by leveraging digital signal processing technology.”

Pure EP is an FDA 510(k) cleared non-invasive device that is designed to drive procedural efficiency in cardiac electrophysiology, according to BioSig Technologies. It is designed for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. Clinical data results from a multi-center study of Pure EP showed 93% consensus across blinded reviewers with a 75% overall improvement in intracardiac signal quality and confidence in interpreting Pure EP signals over conventional sources.



Source link

Previous Post

Discovery could affect the search for new Alzheimer’s drugs

Next Post

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

Next Post

Exploring new therapeutic targets and biomarkers for neurodegenerative disorders

Recommended

Accelerating Computer Vision Application Development

5 months ago

Millstone Medical Outsourcing buys MycoScience

4 months ago

Biology underlying pair bonding and parenting may not be dictated by oxytocin receptors, study shows

2 months ago

UKB resident awarded the C. E. Alken Prize for outstanding scientific uro-oncological research

3 months ago

Biochemical and structural evidence demonstrates Omicron mutations are better adapted to mouse ACE2 than to human ACE2

5 months ago

Researchers develop scale to assess antibiotic resistance awareness among healthcare professionals

2 months ago
Medical-Writers-(-white-)

© Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.